the market?
InterMune
NASDAQ: ITMN
9.58
-0.38
(-3.82%)
| Today's Open | $9.87 |
|---|---|
| Previous Close | $9.96 |
| Daily Range | $9.53 - $9.87 |
| 52-Week Range | $7.21 - $12.77 |
| Market Cap | $782.5M |
| P/E Ratio | -3.62 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 826,352 |
| Average Daily Volume | 1,440,152 |
| Current FY EPS | -$2.75 |
How do you think ITMN
will perform against the market?
Top ITMN Bull/Bear Pitches
portefeuille (< 20)
Submitted
December 16, 2011
There are currently 14500 ITMN shares in my "fund" with break-even of around 8.70 USD. http://caps.fool.com/Blogs/fund-trades/678775.
TMFBreakerTAllan (< 20)
Submitted
May 26, 2010
The FDA will likely require another Phase III trial on pirfenidoone. ITMN cannot pay for this now, and will have to dilute shares or partner the drug. Also ITMN 191 although effective will enter the … More
News & Commentary
3 Stocks to Get on Your Watchlist
Are these three stocks about to make a large move?This Drug Needs a Wake-Up Call
Under review since 2008, Merck will have to wait a little longer to see FDA approval of Bridion.5 Stocks Under $10 Worth Buying
It's all about the Hamiltons, baby.A Reacquired Drug Lottery Ticket
Spectrum reacquires the rights to apaziquone from Allergan.Sector
Healthcare
Industry
Drugs
InterMune (ITMN) Description
The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. Website: http://www.intermune.com/
CEO Rating by Glassdoor
More details for InterMune Jobs
InterMune reviews from employees
